Plant monoterpenes do not raise plasma high-density-lipoprotein concentrations in humans

American Journal of Clinical Nutrition

Volumn 68, Issue 5, 1998, Pages 1042-1045

  Cooke, C Justin ^a   Nanjee, M Nazeem ^b   Dewey, Peter ^b   Cooper, Jacqueline A ^b   Miller, George J ^b   Miller, Norman E ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Apolipoprotein A I; Apolipoprotein B; Cholesterol; HDL; High density lipoprotein; LDL; Low density lipoprotein; Men; Monoterpenes; Triacylglycerols

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MENTHOL GLUCURONIDE; ROWACHOL; TERPENE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHYTOCHEMISTRY; RANDOMIZED CONTROLLED TRIAL;

EID: 0031727733     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.5.1042     Document Type: Article

References (33)

1. Gordon DJ, Rifkind BM. High density lipoprotein - the clinical implications of recent studies. N Engl J Med 1989;321:1311-6.
2. NIH Consensus Panel on Triglyceride, High-Density Lipoprotein and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993;269:505-10.
3. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 1991;353:265-7.
4. Paszty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 1994;94:899-903.
5. Fears R, Esmail A, Walker P, Rush WR, Ferres H. Hyperalphalipoproteinaemic activity of BRL 26314. II. Inhibition of atherosclerosis in rabbits. Biochem Pharmacol 1984;33:219-28.
6. Badimon JJ, Fuster V, Badimon L. Role of high density lipoproteins in the regression of atherosclerosis. Circulation 1992;86(suppl): 86-94.
7. Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport. Arterioscler Thromb Vasc Biol 1989;9:785-97.
8. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest 1995; 96:2882-91.
9. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-94.
10. Desai K, Hutton RA, Bruckdorfer KR, Owen JS. Aggregation of isolated platelets is inhibited by the plasma high density lipoprotein subclass HDL-1. Biochem Soc Trans 1986;14:723-4.
11. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
12. Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. J Clin Invest 1981;67:493-502.
13. Miller NE, Bolton CH, Hayes TM, et al. Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subclasses. The Caerphilly and Speedwell Collaborative Heart Disease Studies. J Epidemiol Community Health 1988; 42:220-5.
14. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45.
15. Howard BV, Hannah JS, Heiser CC, et al. Polyunsaturated fatty acids result in greater cholesterol lowering and less triacylglycerol elevation than do monounsaturated fatty acids in a dose-response comparison in a multiracial group. Am J Clin Nutr 1995; 62:392-402.
16. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
17. Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 1989;321:436-41.
18. Lewis B, Katan M, Merkx I, et al. Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet 1981;2:1310-3.
19. Nanjee MN, Verhagen H, van Poppel G, et al. Do dietary phytochemicals with cytochrome P-450 enzyme-inducing activity increase high-density lipoprotein concentrations in humans? Am J Clin Nutr 1996;64:706-11.
20. Benko S, Macher A, Szarvas F, Tiboldi T. Effect of essential oils on atherosclerosis of cholesterol-fed rabbits. Nature 1961;190:731-2.
21. Hordinsky BZ, Hordinsky W. Rowachol-seine verwendung bei hyperlipidämie. (Rowacho - its use in hyperlipidemia.) Arch Arzneither 1979;1:45-51 (in German).
22. Bell GD, Bradshaw JP, Burgess A, et al. Elevation of serum high density lipoprotein cholesterol by Rowachol, a proprietary mixture of six pure monoterpenes. Atherosclerosis 1980;36:47-54.
23. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:8-15.
24. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700-8.
25. Stampfer MK, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373-81.
26. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996;75:767-71.
27. Nanjee MN, Miller NE. Sequential microenzymatic assay of cholesterol, triglycerides and phospholipids in a single aliquot. Clin Chem 1996;42:915-26.
28. Demacker PNM, Hijmans AGM, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem 1980;26:1775-9.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
30. Nanjee MN, Crouse JR, King JM, et al. Effects of intravenous infusion of lipid-free apo A-I in humans. Arterioscler Thromb Vasc Biol 1996;16:1203-14.
31. Bell GD, Henry DA, Richmond CR. A specific g.l.c assay for menthol in urine. Br J Clin Pharmacol 1981;12:281 (abstr).
32. Nanjee MN, Miller NE. Evaluation of long-term frozen storage of plasma for measurement of high-density lipoprotein and its subfractions by precipitation. Clin Chem 1990;36:783-7.
33. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992;68:60-6.